May 7, 2013 by Mark RogersG4S Hurt by Margin SqueezeG4S reveals 6% organic growth in the first quarter.
May 7, 2013 by Mark RogersSchool Buses Drive Growth at National Express GroupNational Express Group issues an upbeat first-quarter update.
May 3, 2013 by Mark RogersOrders Grow $700 Million at Kentz CorporationKentz Corporation delivers an upbeat first-quarter update.
May 3, 2013 by Mark RogersMan Group Clears $470 Million Debt With Surplus CashMan Group reveals disappointing first-quarter client outflows.
May 2, 2013 by Mark RogersPremiums Grow 7% at RSA InsuranceRSA Insurance Group reports "encouraging" start to 2013.
May 2, 2013 by Mark RogersDo Tomorrow's Results Matter for Royal Bank of ScotlandA preview of Friday's Royal Bank of Scotland's first-quarter results.
May 2, 2013 by Mark RogersWhy I'm Happy to Hold Greggs Two Fools discuss the recent profit warning from Greggs.
May 1, 2013 by Mark RogersProfits Slide 70% at Spirent CommunicationsSpirent Communications reports first-quarter results in line with expectations.
Apr 29, 2013 by Mark RogersRentokil Initial Sells City Link for 1 PoundRentokil Initial reports declining first-quarter profit.
Apr 29, 2013 by Mark RogersProfit Warning at GreggsGreggs issues a disappointing first-quarter update.
Apr 26, 2013 by Mark RogersPearson Hikes Dividend by 7% to Yield 3.9%Pearson issues a first-quarter interim statement.
Apr 25, 2013 by Mark RogersSales at Taylor Wimpey Boosted by Government SchemeTaylor Wimpey issues a positive first-quarter update.
Apr 25, 2013 by Mark RogersProfits Dive 31% at AstraZenecaAstraZeneca issues its first-quarter results.
Apr 24, 2013 by Mark RogersU.K. Sales Grow 6% at CarpetrightCarpetright issues its first-quarter trading statement.
Apr 24, 2013 by Mark RogersNew Business Sales Grow 24% at Standard LifeStandard Life reveals a 2.8 billion-pound inflow of assets.
Apr 24, 2013 by Mark RogersGlaxoSmithKline Lifts Dividend 6% to Yield 4.5%GlaxoSmithKline plans to sell Lucozade and Ribena.
Apr 23, 2013 by Mark RogersAstraZeneca Faces "Tremendous Operational Challenges"A major AstraZeneca shareholder gives the pharma group's boss a vote of confidence.
Apr 22, 2013 by Mark RogersReckitt Benckiser Group Reveals Sales Up 7%Reckitt Benckiser Group Plc issues its first-quarter results.
